S9624 Ifosfamide in Treating Patients With Meningeal Tumors
Recruiting in Palo Alto (17 mi)
+69 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Southwest Oncology Group
No Placebo Group
Prior Safety Data
Approved in 3 Jurisdictions
Trial Summary
What is the purpose of this trial?
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ifosfamide in treating patients with meningeal tumors that have recurred or that cannot be removed surgically.
Eligibility Criteria
Inclusion Criteria
Malignant meningioma
Intracranial hemangiopericytoma
Fibrosarcoma
See 7 more
Treatment Details
Interventions
- Ifosfamide (Alkylating agents)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ifosfamideExperimental Treatment1 Intervention
ifosfamide
Ifosfamide is already approved in United States, European Union, Canada for the following indications:
🇺🇸 Approved in United States as Ifex for:
- Testicular cancer
- Ovarian cancer
- Soft tissue sarcoma
- Ewing's sarcoma
- Non-Hodgkin's lymphoma
🇪🇺 Approved in European Union as Ifex for:
- Testicular cancer
- Ovarian cancer
- Soft tissue sarcoma
- Ewing's sarcoma
- Non-Hodgkin's lymphoma
🇨🇦 Approved in Canada as Ifex for:
- Testicular cancer
- Ovarian cancer
- Soft tissue sarcoma
- Ewing's sarcoma
- Non-Hodgkin's lymphoma
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
CCOP - Colorado Cancer Research Program, IncorporatedDenver, CO
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimore, MD
Tuft-New England Medical CenterBoston, MA
Veterans Affairs Medical Center - MinneapolisMinneapolis, MN
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Southwest Oncology GroupLead Sponsor
SWOG Cancer Research NetworkLead Sponsor
Eastern Cooperative Oncology GroupCollaborator
National Cancer Institute (NCI)Collaborator